Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas
Andrea Piunti,Rintaro Hashizume,Marc A Morgan,Elizabeth T Bartom,Craig M Horbinski,Stacy A Marshall,Emily J Rendleman,Quanhong Ma,Yoh-hei Takahashi,Ashley R Woodfin,Alexander V Misharin,Nebiyu A Abshiru,Rishi R Lulla,Amanda M Saratsis,Neil L Kelleher,C David James,Ali Shilatifard
DOI: https://doi.org/10.1038/nm.4296
IF: 82.9
2017-02-27
Nature Medicine
Abstract:Nucleosomes containing mutant K27M histones in diffuse intrinsic pediatric gliomas (DIPG) exclude PRC2 binding and recruit BET bromodomain proteins; however, residual PRC2-dependent repression of specific loci, is required for DIPG oncogenesis. These results provide a rationale for targeting these epigenetic regulators in patients.
biochemistry & molecular biology,cell biology,medicine, research & experimental
What problem does this paper attempt to address?